VICTORIA KRESSE: Open Payments
NPI 1962758649 · NEWTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 38 payments from 16 companies in 2025. Trend: 2023 $755 · 2024 $313 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $107 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $80 |
| Novo Nordisk Inc | 4 | $75 |
| Amgen Inc. | 5 | $74 |
| PFIZER INC. | 4 | $68 |
| BridgeBio Pharma, Inc. | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Medtronic, Inc. | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $22 |
Products named: LEQVIO, LifeVest, Wegovy, REPATHA, Attruby, VYNDAQEL, ELIQUIS, SYMPLICITY G3.
Industry payments across NJ — which companies pay providers there.
